Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.
about
Peptide-Based Treatment: A Promising Cancer TherapyOrigin of anti-tumor activity of the cysteine-containing GO peptides and further optimization of their cytotoxic properties.Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.Novel delivery approaches for cancer therapeutics.Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingIdentification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressureTargeting glioblastoma via intranasal administration of Ff bacteriophages.Selection of Lung Cancer-Specific Landscape Phage for Targeted Drug Delivery.Relevance of splicing on tumor-released exosome landscape: implications in cancer therapeutics.A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells.Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning.A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.
P2860
Q26777032-E920C725-26A5-43B5-A397-99DD33D37018Q29248355-D74C0B6A-BE3C-4EA9-A0D1-4FCB8C1253F3Q30358614-9E64703F-A28A-4F06-A3E9-BDAA31A9EB2CQ30359589-8B200C90-A0F0-4890-BF6A-E012D4DE548FQ30368171-4392884A-1A9F-4552-B2D7-D53EDA705252Q30418500-A6AAF8BC-1F74-41C7-BE86-AF84FAEB4F62Q30851553-240C3DB9-30C8-4F1D-B22D-E7F27747933DQ34343508-8B15E930-3765-44FA-8F59-2C2F1366E7E9Q35651275-7C1E2EA2-DC6A-49EF-9D14-8AE807E2F591Q35994412-793FE59F-3BC4-4CBA-8247-8B16F70A47A8Q38271955-F52F917D-4AED-4AD1-B8C2-BF89A9E1EA83Q38843320-E5DFE9F4-7D37-4552-9750-F02E4F9D66C6Q47298251-171400E5-C0C3-47E1-AAD6-B0AB7FA1D01EQ52958205-B274F253-81E4-45AF-8696-A5A71ACD6B42Q54969380-3FFAED9F-62BB-45DB-BC44-EFBB07A6DAB4Q55399318-E3DFCA6B-DCB4-455F-8CF0-E1181F661ADA
P2860
Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification and characteriz ...... or non-small cell lung cancer.
@ast
Identification and characteriz ...... or non-small cell lung cancer.
@en
type
label
Identification and characteriz ...... or non-small cell lung cancer.
@ast
Identification and characteriz ...... or non-small cell lung cancer.
@en
prefLabel
Identification and characteriz ...... or non-small cell lung cancer.
@ast
Identification and characteriz ...... or non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Identification and characteriz ...... or non-small cell lung cancer.
@en
P2093
Bethany Powell Gray
Dorothy Cupka
James Issac
John D Minna
Kathlynn C Brown
Lauren Averett Byers
Lixia Diao
Michael J McGuire
Naveen Pattisapu
P2860
P2888
P356
10.1038/SREP04480
P407
P577
2014-03-27T00:00:00Z